Trial Profile
The efficacy and cellular immune mechanism of NAs in the treatment of patients with chronic hepatitis B after multiple antiviral treatment failures
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Aug 2016
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 24 Nov 2015 New trial record
- 01 Oct 2015 Results published in the Hepatology Research